Abstract. In machine learning terms DNA (gene) chip data is unusual in having thousands of attributes (the gene expression values) but few (<100) records (the patients). A GP based method for both feature selection and generating simple models based on a few genes is demonstrated on cancer data.
Introduction
The problem of over fitting is a dominant concern with machine learning approaches to DNA chip data. These medical data are characterised by class imbalance, non-linear response, high noise, large numbers of attributesand few examples. In 2002 Pomeroy et al. published DNA chip data for 60 cancer patients [13] . Their attempts to model the data using unsupervised learning techniques (self organising maps) were unsuccessful at predicting patient survival (p. 441) however they claim statistically significant success using nearest neighbour and other supervised learning techniques. Li et al. [11] obtained good results using three nearest neighbours after selecting genes with a multi-run evolutionary approach on similarly sized DNA expression data. ( [17] surveys both supervised and unsupervised data mining techniques used with microarray data.)
Genetic programming (GP) has been used with DNA chip data previously. For example [3] used it with time sequences of expression levels in yeast to ascribe functions to genes. However here we consider much smaller static expression data sets to classify, either the patient as a whole or specific tissues (e.g. cancer tissues). Classifications might in future suggest particular treatments. Also identification of predictive genes may aid understanding of causes and hence treatments of diseases. While Moore et al. [12] showed GP can be used to fit DNA expression data, we show it can be used to find very simple models, with consequently little danger of over fitting. There follows an experiment which shows linear discrimination using two genes found by GP (from a total of 7129) gives similar performance to that given in [13] .
Cancer DNA chip data
Pomeroy et al.'s [13] "Gene Expression-Based Classification and Outcome Prediction of Central Nervous System Embryonal Tumors" data was copied from http://wwwgenome.wi.mit.edu/mpr/publications/projects/CNS/Pomeroy et al 0G04850 11142001 datasets.zip. Gene descriptors and patient identification were removed from Dataset C MD outcome.gct and Dataset C MD outcome.xls, which were then merged and transposed. There are 7129 signed integer gene expression values for each of the 60 patients, of whom 39 survived.
Leave one out cross validation
n-fold cross validation allows one to estimate how well a learning technique will perform on unseen data without reserving a sizeable volume of data for testing. The data is divided into (say n = 5) equal numbers of records, known as folds. The learning system is trained on all records except one fold. Its performance on the remaining records is measured. Then the same system is trained again but this time leaving out another fold. The performance of the learning system is estimated by taking the mean of the (five) performance measurements. As always, care must be taken that their is no cross contamination which might allow knowledge about patterns in the test data (i.e. the test folds) to leak into the training process.
Since there are only a very few training examples, we go to the extreme of having as many folds as their are records (60). I.e., the GP is trained sixty times using 59 patient records. Leave one out gives an almost unbiased estimate but its variance may be high [4] . Each time the performance of the evolved model is measured by seeing if it can predict the survival of the remaining patient. Because genetic programming is a stochastic process, the GP is run ten times (cf. [2] ), making a total of 600 runs for each stage in the experiment.
Genetic programming
The individuals in the GP population consist of five trees. At crossover one of the five is chosen and size fair crossover [6] occurs only between that tree in first and second parents. The remaining four trees are copied unchanged from the first parent [5] . The GP's prediction is positive if the sum of the floating point values returned by the five trees is greater than or equal to zero. While, in this work, having multiple trees, does not directly increase the power of the representation, it may help by making it easier for different parts of the individuals to evolve to specialise in solving different parts of a problem. Soule [16] and Rodriguez-Vazquez and Oliver-Morales [15] and ourselves [8] [9] [10] report some success with it. Gene expression values are represented as floating point numbers. We retained our use of area under the (convex hull of) the receiver operating characteristics (ROC) curve as the fitness measure [10] . But for speed and simplicity only a single threshold point on the curve was used. This collapses fitness to 1 2 (TP + (1 − FP) ), where TP = true positive rate and F P = false positive rate. I.e. the mean of the accuracy on the positive examples and the accuracy on the negative. See Table 1 for other GP parameters. 
Mining genes from genetic programming
The first group of 600 GP runs produced 600 best of run models. Together they contained 6970 of the 7129 DNA chip attributes. Some attributes were used much more than others. We selected the 404 genes which occurred in ten or more best of run individuals ( [12] used nine as a cut point in similar data). We re-ran the GP a second 600 times. All the 404 genes were used by at least one of the 600 best of run individuals. However again the distribution of genes across models was highly non uniform with only two genes occurring in more than 100 models (see Figure 1) . Genes U08998 at and U41737 at occurred in 182 and 193 best of run models. The first gene (TAR RNA binding protein (TRBP) mRNA, U08998 at) is known to promote the formation or development of cancerous tumours [1] but [13, supplemental] says it is not amongst the top marker genes selected by signal-to-noise (mean) ratio (it is in the middle of the top 200). The second gene (Pancreatic beta cell growth factor (INGAP) mRNA, U41737 at) is not amongst [13, supplemental]'s top 200 but may be involved in the onset of diabetes [14] . Pomeroy et al. [13] , heavily thresholded the data for these two genes (cf. Figure 2 ) which may explain why they were not identified. However their consistently low expression values do raise questions about data pre-processing and the practicality of using either gene in diagnostics tests.
We felt that applying the full power of genetic programming to noisy data was liable to generate overly complex models. Instead in a final 600 runs we severely limited the GP's expression and learning abilities. The model size and function set were both limited so models could only contain either no functions at all or a single IF statement and only the initial random generation was used.
The leave one out estimate of the accuracy of the random two gene models is 68%. Pomeroy et al. [13] , claims 47/60 (78% accuracy) with a k = 5 nearest neighbour classifier using 8 genes. While their classifiers may be better, they are more complex. Also, with only 60 cases, we cannot show the difference between 68 and 78% is significant (σ = 6%).
Three quarters of all cases (147 of 192) where the random models made incorrect predictions can be traced to 15 cases which are significantly ( p < 0.01) harder than the overall leave one out estimate of accuracy (68%) would suggest. These are shown with Figure 1 . Number of best of run GP models in 600 second stage GP runs which included each of the 404 genes selected by the first stage from the total of 7129 genes. Genes more than 4σ from mean are labelled. solid markings in Figure 2 . In 39 of the remaining 45 cases the random two gene models made the correct prediction more often than not. Figure 2 shows the patient data. It is clear that the cases which prove hard on the leave one out two gene trials are hard because they lie within clusters of patients with the opposite outcome. Figure 2 also shows the decision boundaries of two typical random two gene models. Over the range of the data, one is linear and the other is piecewise linear. While there many possible views of the data, the intermixing of survivors (squares) and non-survivors (triangles) in Figure 2 suggests that gene expression data cannot be 100% predictive and that there are other important factors.
Discussion
In general optimal selection of features (genes in our case) requires exponential effort, even for simple fixed interaction between features. Since optimal selection is not feasible, heuristics are used. Traditionally either forward or backward feature selection are used. They use a fixed interaction rule between features (typically linear) and sequentially process features one at a time. Either all features are included and the set is trimmed one feature at a time or no features are initialy included, then the most informative is added, followed by the next (given those already selected) and so on. There is no scope for going back and re-considering features that have already been discarded (or selected). Figure 2 . Expression of two genes from 7129 used to predict outcome of cancer treatment [13] . The piecewise linear decision boundary is the best of 500 random programs using just these two genes (from the first of ten runs leaving out patient record 6). Solid shapes indicate cases which are significantly harder to predict. The linear boundary produced when leaving out a different record (37) is shown dotted. It predicts survival if 2 × U08998 at + U41737 at < −43 and makes only one more error. Dashed rectangle indicates threshold (20) used by Pomeroy et al. [13] , only nine patient records are not affected by such thresholding.
Genetic programming is an alternative heuristic. Instead of a fixed combination rule, it allows almost any means of combining a number of features. (GP is also free to select the number of features.) At any one time, there isn't a single set of selected features, but instead a population of individuals using features. Evolution is free to add/remove multiple features (rather than one) and can re-consider previous selection/removal decisions as new combinations are tried.
We have rerun the experiments with different settings. Naturally in detail each run is very different. While, with ten replications of each validation fold, no significant difference in the two main genes was found, a different GP study might give different models (of similar performance).
It is clear from this, and similar, data sets that there are many ways to make predictions from non-linear combinations of subsets of genes whose accuracies are not significantly different. GP is a general powerful, noise tolerant, way of finding them, which can yield easily interpretable functions, rather than black boxes.
Conclusions
The enormous width of DNA gene chip data makes over fitting an ever present danger, particularly with powerful machine learning approaches. Genetic programming, in combination with leave one out cross validation and a principled objective function (which takes into account the class imbalance often found in Biological data sources) has been used to evolve many non-linear functions of gene expression values. The goal has been to whittle down the thousands of data attributes (gene expression measurements) into a few predictive ones.
We were surprised to find only one or two genes are needed to make predictions and by the simplicity of the models found by genetic programming. These results strongly suggest deterministic algorithms which only allow linear interaction but which are able to deal effectively with thousands of data attributes will also do well on this dataset. However the low data values given for the expression of the two genes raise questions about the preprocessing required when performing gene chip experiments. Other experiments (also on treatment outcome in animal and Human studies) confirm GP as a potentially valuable gene selection technique when extracting knowledge from DNA chip data.
